Courtesy of Benzinga.
Shares of Nu Skin Enterprises (NYSE: NUS) traded sharply lower on Thursday afternoon following a report from Reuters that Stanford University had sent the company a cease and desist letter in regards to an improper representation of a relationship.
Nu Skin had been trending lower throughout the day after Citron Research published a negative report on the company. The headlines about Stanford only accelerated the decline.
Shares of Nu Skin were trading near $40.45 on Thursday afternoon.
